Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07442136 · ClinicalTrials.gov registry record · Phase 3
Clinical Study to Assess the Efficacy of New Toothpaste Containing SnF as Compared to Colgate Cavity Protection Toothpaste on the Reduction of Enamel Erosion
A Phase 3 study of Enamel Erosion, sponsored by Colgate Palmolive.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07442136 is a Phase 3 study of Enamel Erosion that is actively recruiting participants, run by Colgate Palmolive. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07442136, a Phase 3 study of Enamel Erosion, is actively recruiting participants, sponsored by Colgate Palmolive.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if a new toothpaste can prevent enamel erosion in healthy adults. Researchers will compare the test toothpaste to a control toothpaste to see if there is a difference in erosion levels. Participants will brush twice a day for two minutes with their assigned toothpaste.
Conditions Studied
Interventions
- DRUG New Toothpaste Containing SnF
- DRUG Fluoride Toothpaste
Study Locations (1)
Texas
- School of Dentistry, University of Texas Health San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-03-03 |
| Est. Completion | 2026-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07442136
The ClinicalTrials.gov registry entry for NCT07442136 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Enamel Erosion appearing as the primary indexed condition, and to 2 interventions - of which New Toothpaste Containing SnF is the first listed.
NCT07442136 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07442136 about?
NCT07442136 is a clinical study titled "Clinical Study to Assess the Efficacy of New Toothpaste Containing SnF as Compared to Colgate Cavity Protection Toothpaste on the Reduction of Enamel Erosion". The goal of this clinical trial is to learn if a new toothpaste can prevent enamel erosion in healthy adults. Researchers will compare the test toothpaste to a control toothpaste to see if there is a difference in erosion levels. Participants will brush twice a day for two minutes with their assigne...
What is the current status of trial NCT07442136?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2026-03-03. Estimated completion is 2026-04.
What conditions does trial NCT07442136 study?
This clinical trial studies the following conditions: Enamel Erosion.
What interventions are being tested in trial NCT07442136?
The interventions under investigation include: New Toothpaste Containing SnF (DRUG), Fluoride Toothpaste (DRUG).
Who is sponsoring clinical trial NCT07442136?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07442136 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Enamel Erosion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.